NCT02812667 2025-11-12
Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)
University of California, San Diego
Phase 1 Completed
Clinical Trials
3 trialsNCT00630110 2011-08-16
Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer
Nereus Pharmaceuticals, Inc.
Phase 1/2 Completed
NCT00322608 2011-01-10
Study of the Vascular Disrupting Agent NPI-2358 in Patients With Advanced Solid Tumors or Lymphoma
Nereus Pharmaceuticals, Inc.
Phase 1 Completed